Literature DB >> 26662859

The deadly landscape of pro-apoptotic BCL-2 proteins in the outer mitochondrial membrane.

Mark P A Luna-Vargas1,2, Jerry E Chipuk1,2,3,4,5.   

Abstract

Apoptosis is a biological process that removes damaged, excess or infected cells through a genetically controlled mechanism. This process plays a crucial role in organismal development, immunity and tissue homeostasis, and alterations in apoptosis contribute to human diseases including cancer and auto-immunity. In the past two decades, significant efforts have focused on understanding the function of the BCL-2 proteins, a complex family of pro-survival and pro-apoptotic α-helical proteins that directly control the mitochondrial pathway of apoptosis. Diverse structural investigations of the BCL-2 family members have broadened our mechanistic understanding of their individual functions. However, an often over-looked aspect of the mitochondrial pathway of apoptosis is how the BCL-2 family specifically interacts with and targets the outer mitochondrial membrane to initiate apoptosis. Structural information on the relationship between the BCL-2 family and the outer mitochondrial membrane is missing; likewise, knowledge of the biophysical mechanisms by which the outer mitochondrial membrane affects and effects apoptosis is lacking. In this mini-review, we provide a current overview of the BCL-2 family members and discuss the latest structural insights into BAK/BAX activation and oligomerization in the context of the outer mitochondrial membrane and mitochondrial biology.
© 2015 FEBS.

Entities:  

Keywords:  BAK; BAX; BCL-2 family; MOMP; Structure; apoptosis; lipids; membrane; mitochondria; mitochondrial landscape

Mesh:

Substances:

Year:  2016        PMID: 26662859      PMCID: PMC4907887          DOI: 10.1111/febs.13624

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  118 in total

1.  Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists.

Authors:  J M McDonnell; D Fushman; C L Milliman; S J Korsmeyer; D Cowburn
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

2.  Structural changes in the BH3 domain of SOUL protein upon interaction with the anti-apoptotic protein Bcl-xL.

Authors:  Emmanuele Ambrosi; Stefano Capaldi; Michele Bovi; Gianmaria Saccomani; Massimiliano Perduca; Hugo L Monaco
Journal:  Biochem J       Date:  2011-09-01       Impact factor: 3.857

3.  Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers.

Authors:  Kyoung Joon Oh; Pawan Singh; Kyungro Lee; Kelly Foss; Shinyoub Lee; Minji Park; Steffi Lee; Sreevidya Aluvila; Matthew Park; Puja Singh; Ryung-Suk Kim; Jindrich Symersky; D Eric Walters
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

4.  Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.

Authors:  Sreekanth Rajan; Minjoo Choi; Kwanghee Baek; Ho Sup Yoon
Journal:  Proteins       Date:  2015-05-23

5.  Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane.

Authors:  Tomomi Kuwana; Mason R Mackey; Guy Perkins; Mark H Ellisman; Martin Latterich; Roger Schneiter; Douglas R Green; Donald D Newmeyer
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

6.  Bak core and latch domains separate during activation, and freed core domains form symmetric homodimers.

Authors:  Jason M Brouwer; Dana Westphal; Grant Dewson; Adeline Y Robin; Rachel T Uren; Ray Bartolo; Geoff V Thompson; Peter M Colman; Ruth M Kluck; Peter E Czabotar
Journal:  Mol Cell       Date:  2014-08-28       Impact factor: 17.970

Review 7.  How do I kill thee? Let me count the ways: p53 regulates PARP-1 dependent necrosis.

Authors:  Rana Elkholi; Jerry E Chipuk
Journal:  Bioessays       Date:  2013-10-24       Impact factor: 4.345

8.  BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins.

Authors:  Levi J Beverly; Lauren A Howell; Maria Hernandez-Corbacho; Lavona Casson; Jerry E Chipuk; Leah J Siskind
Journal:  Biochem J       Date:  2013-05-15       Impact factor: 3.857

9.  Anti-apoptotic Bcl-2 Family Proteins Disassemble Ceramide Channels.

Authors:  Leah J Siskind; Laurence Feinstein; Tingxi Yu; Joseph S Davis; David Jones; Jinna Choi; Jonathan E Zuckerman; Wenzhi Tan; R Blake Hill; J Marie Hardwick; Marco Colombini
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

Review 10.  Apoptosome structure, assembly, and procaspase activation.

Authors:  Shujun Yuan; Christopher W Akey
Journal:  Structure       Date:  2013-04-02       Impact factor: 5.006

View more
  33 in total

1.  Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition.

Authors:  Nathan W Cummins; Amy M Sainski-Nguyen; Sekar Natesampillai; Fatma Aboulnasr; Scott Kaufmann; Andrew D Badley
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

2.  Lipid-modulation of membrane insertion and refolding of the apoptotic inhibitor Bcl-xL.

Authors:  Victor Vasquez-Montes; Mauricio Vargas-Uribe; Nitin K Pandey; Mykola V Rodnin; Ralf Langen; Alexey S Ladokhin
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2019-04-18       Impact factor: 3.036

Review 3.  Physiological and pharmacological modulation of BAX.

Authors:  Adam Z Spitz; Evripidis Gavathiotis
Journal:  Trends Pharmacol Sci       Date:  2021-11-27       Impact factor: 14.819

4.  Yes, MAM!

Authors:  Robert E Means; Samuel G Katz
Journal:  Mol Cell Oncol       Date:  2021-05-19

5.  Plasmodium infection suppresses colon cancer growth by inhibiting proliferation and promoting apoptosis associated with disrupting mitochondrial biogenesis and mitophagy in mice.

Authors:  Xin Yao; Yujie Cao; Li Lu; Yuanxia Xu; Hao Chen; Chuanqi Liu; Dianyi Chen; Kexue Wang; Jingxiang Xu; Runqi Fang; Hui Xia; Jiangyan Li; Qiang Fang; Zhiyong Tao
Journal:  Parasit Vectors       Date:  2022-06-06       Impact factor: 4.047

Review 6.  Physiological and Pharmacological Control of BAK, BAX, and Beyond.

Authors:  Mark P A Luna-Vargas; Jerry Edward Chipuk
Journal:  Trends Cell Biol       Date:  2016-08-04       Impact factor: 20.808

7.  Grouper iridovirus GIV66 is a Bcl-2 protein that inhibits apoptosis by exclusively sequestering Bim.

Authors:  Suresh Banjara; Jiahao Mao; Timothy M Ryan; Sofia Caria; Marc Kvansakul
Journal:  J Biol Chem       Date:  2018-02-26       Impact factor: 5.157

8.  Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.

Authors:  Michael V Ortiz; Saima Ahmed; Melissa Burns; Anton G Henssen; Travis J Hollmann; Ian MacArthur; Shehana Gunasekera; Lyvia Gaewsky; Gary Bradwin; Jeremy Ryan; Anthony Letai; Ying He; Arlene Naranjo; Yueh-Yun Chi; Michael LaQuaglia; Todd Heaton; Paolo Cifani; Jeffrey S Dome; Samantha Gadd; Elizabeth Perlman; Elizabeth Mullen; Hanno Steen; Alex Kentsis
Journal:  JCI Insight       Date:  2019-08-08

9.  5-FU preferably induces apoptosis in BRAF V600E colorectal cancer cells via downregulation of Bcl-xL.

Authors:  Tongfei Shi; Mohan Gao; Meihui He; Fengli Yue; Yawei Zhao; Madi Sun; Kan He; Li Chen
Journal:  Mol Cell Biochem       Date:  2019-07-27       Impact factor: 3.842

10.  Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia.

Authors:  Jean Carlos Lipreri da Silva; Juan Luiz Coelho-Silva; Keli Lima; Hugo Passos Vicari; Mariana Lazarini; Leticia Veras Costa-Lotufo; Fabiola Traina; João Agostinho Machado-Neto
Journal:  Cell Oncol (Dordr)       Date:  2021-07-01       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.